Related Experiment Videos
Oxidative stress and Parkinson's disease
A D Owen1, A H Schapira, P Jenner
1Neurodegenerative Diseases Research Centre, King's College London, United Kingdom.
Annals of the New York Academy of Sciences
|June 15, 1996
Summary
Reduced glutathione levels in the substantia nigra may signal early Parkinson's disease. Oxidative stress, indicated by glutathione depletion, is a key factor in neurodegeneration, warranting further study.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- The mechanism of cell death in Parkinson's disease (PD) substantia nigra is unknown.
- Biochemical changes in PD substantia nigra (increased iron, inhibited Complex I, decreased reduced glutathione; GSH) suggest oxidative stress involvement.
- GSH decrease may be an early PD marker, also seen in presymptomatic stages (incidental Lewy body disease).
Purpose of the Study:
- To investigate the role of oxidative stress and glutathione depletion in Parkinson's disease pathogenesis.
- To understand the specific changes in glutathione levels and related enzyme activity in the substantia nigra.
Main Methods:
- Analysis of biochemical changes in the substantia nigra of Parkinson's disease patients.
- Comparison of glutathione levels in Parkinson's disease with other neurodegenerative disorders.
- Enzyme activity assays for the glutathione cycle.
- Experimental depletion of GSH in a rat model (using L-buthionine-[S, R]-sulfoxamine; BSO) to assess 6-hydroxydopamine (6-OHDA) toxicity.
Main Results:
- GSH is globally depleted in the substantia nigra in Parkinson's disease, not in other basal ganglia disorders.
- Glutathione cycle enzyme activity is normal, except for increased gamma-glutamyltranspeptidase, potentially increasing GSH degradation.
- Experimental GSH depletion potentiates 6-OHDA toxicity but doesn't cause nigrostriatal degeneration alone.
Conclusions:
- Oxidative stress, particularly GSH depletion, is a significant factor in substantia nigra degeneration in Parkinson's disease.
- Further research is warranted to elucidate the precise role of oxidative stress in Parkinson's disease progression.
- Increased gamma-glutamyltranspeptidase activity may contribute to glutathione loss in Parkinson's disease.